focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.84
Bid: 7.76
Ask: 7.92
Change: -0.06 (-0.76%)
Spread: 0.16 (2.062%)
Open: 7.90
High: 0.00
Low: 0.00
Prev. Close: 7.90
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Dec 2016 10:04

RNS Number : 4518R
Oxford BioDynamics PLC
09 December 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Oxford BioDynamics plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

ODEY ASSET MANAGEMENT LLP

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

06 DECEMBER 2016

6. Date on which issuer notified:

08 DECEMBER 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

REACHES 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Share

(GB00BD5H8572)

0

0

8,609,823

8,609,823

10.00%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,609,823

10.00%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Odey European Inc. holds 4.28%. All other funds hold less than 3%.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

FERGUS LEE

15. Contact telephone number:

020 72081400

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEANEEAKFFF
Date   Source Headline
22nd Mar 20232:22 pmRNSHolding(s) in Company
15th Mar 202311:43 amRNSAIM Rule 17 Schedule 2(g) Update
3rd Mar 20234:33 pmRNSPublication of FY22 Annual Report
23rd Feb 202310:36 amRNSPDMR Dealing
6th Feb 20237:00 amRNSOBD Prostate Screening EpiSwitch Blood Test Update
27th Jan 20232:36 pmRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSPreliminary Results and Notice of AGM
21st Dec 20227:00 amRNSNotice of FY22 Results and Investor Webinar
19th Dec 20227:00 amRNSOBD in San Francisco for JPM Healthcare conf 2023
16th Dec 20227:00 amRNSInitial assessment of EpiSwitch assay in ALS trial
14th Dec 202212:35 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSExercise period extension - existing share options
1st Dec 20222:14 pmRNSHolding(s) in Company
28th Nov 20227:00 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSDiscussion about EpiSwitch CiRT at Key Summit
18th Nov 20224:40 pmRNSSecond Price Monitoring Extn
18th Nov 20224:35 pmRNSPrice Monitoring Extension
14th Nov 202211:10 amRNSDirector/PDMR Shareholding
9th Nov 20224:07 pmRNSDirector/PDMR Shareholding
8th Nov 20221:57 pmRNSHolding(s) in Company
2nd Nov 202212:37 pmRNSHolding(s) in Company
2nd Nov 202212:35 pmRNSHolding(s) in Company
2nd Nov 202212:33 pmRNSHolding(s) in Company
1st Nov 20221:20 pmRNSTotal Voting Rights
1st Nov 202212:39 pmRNSTotal Voting Rights
1st Nov 202210:57 amRNSHolding(s) in Company
31st Oct 202211:05 amRNSHolding(s) in Company
31st Oct 202211:04 amRNSHolding(s) in Company
31st Oct 202211:02 amRNSHolding(s) in Company
31st Oct 202210:58 amRNSHolding(s) in Company
31st Oct 202210:57 amRNSHolding(s) in Company
31st Oct 202210:56 amRNSHolding(s) in Company
28th Oct 20222:36 pmRNSHolding(s) in Company
27th Oct 202212:09 pmRNSResult of General Meeting, Director/PDMR Dealings
25th Oct 20222:30 pmRNSResult of Open Offer
7th Oct 202212:00 pmRNSProposed Placing and Open Offer
3rd Oct 20227:00 amRNSUS Reimbursement Code for CiRT now available
15th Sep 20227:00 amRNSESMO data highlights unique benefit of EpiSwitch
6th Sep 20227:00 amRNSCiRT highlighted at ESMO 2022 presentation
5th Jul 20227:00 amRNSUS reimbursement code for EpiSwitch® CiRT
1st Jul 20224:13 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSHalf-year Report
21st Jun 20227:00 amRNSEpiSwitch® CiRT now available in the UK
17th Jun 20227:00 amRNSNotice of Interim Results Webinar
15th Jun 20227:00 amRNSNotice of Results
14th Jun 20227:00 amRNSOBD EpiSwitch® CiRT well received at ASCO 2022
20th May 20223:50 pmRNSDirector/PDMR Shareholding
20th May 20227:00 amRNSPDMR Dealing / Grant of Share Options
13th May 20223:57 pmRNSPDMR Dealing / Grant of Share Options
5th May 20227:00 amRNSOBD to present CiRT clinical utility data at ASCO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.